Pegasus Partners Ltd. Exact Sciences Corp Transaction History

Pegasus Partners Ltd.

$991 Million
Q2 2024

A detailed history of Pegasus Partners Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, Pegasus Partners Ltd. holds 21,179 shares of EXAS stock, worth $1.41 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

21,179

Previous 22,066 4.02%

Holding current value

$1.41 Million

Previous $1.52 Million 41.3%

% of portfolio

0.09%

Previous 0.16%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$41.33 - $74.26 $36,659 - $65,868	-887 Reduced 4.02%	21,179 $894,000
Q2 2023 Aug 04, 2023	SELL	$62.68 - $95.05 $16,798 - $25,473	-268 Reduced 1.2%	22,066 $2.07 Million
Q1 2023 May 10, 2023	BUY	$47.19 - $70.77 $32,985 - $49,468	699 Added 3.23%	22,334 $1.51 Million
Q3 2022 Nov 10, 2022	BUY	$31.97 - $49.37 $1,118 - $1,727	35 Added 0.16%	21,635 $703,000
Q2 2022 Aug 12, 2022	SELL	$35.61 - $76.23 $334,734 - $716,562	-9,400 Reduced 30.32%	21,600 $851,000
Q1 2022 May 13, 2022	SELL	$57.56 - $82.54 $9,382 - $13,454	-163 Reduced 0.52%	31,000 $2.17 Million
Q4 2021 Feb 09, 2022	BUY	$72.5 - $100.68 $112,230 - $155,852	1,548 Added 5.23%	31,163 $2.43 Million
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $19,401 - $26,670	215 Added 0.73%	29,615 $2.83 Million
Q2 2021 Aug 13, 2021	BUY	$93.66 - $139.27 $1.25 Million - $1.86 Million	13,380 Added 83.52%	29,400 $3.66 Million
Q1 2021 May 14, 2021	BUY	$116.57 - $155.01 $1.28 Million - $1.71 Million	11,000 Added 219.12%	16,020 $2.11 Million
Q4 2020 Feb 12, 2021	SELL	$99.61 - $142.12 $41,736 - $59,548	-419 Reduced 7.7%	5,020 $665,000
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $189,592 - $265,226	2,600 Added 91.58%	5,439 $555,000
Q2 2020 Aug 12, 2020	BUY	$55.75 - $92.75 $158,274 - $263,317	2,839 New	2,839 $247,000
Q3 2019 Oct 24, 2019	SELL	$90.37 - $122.49 $173,420 - $235,058	-1,919 Closed	0 $0
Q2 2019 Jul 30, 2019	SELL	$89.51 - $118.04 $44,755 - $59,020	-500 Reduced 20.67%	1,919 $227,000
Q1 2019 May 13, 2019	SELL	$61.98 - $96.5 $295,954 - $460,787	-4,775 Reduced 66.37%	2,419 $210,000
Q2 2018 Jul 27, 2018	SELL	$37.84 - $69.96 $313,353 - $579,338	-8,281 Reduced 53.51%	7,194 $430,000
Q4 2017 Feb 08, 2018	SELL	$46.49 - $60.51 $503,254 - $655,020	-10,825 Reduced 41.16%	15,475 $813,000
Q3 2017 Nov 09, 2017	BUY	$37.05 - $47.12 $974,414 - $1.24 Million	26,300	26,300 $1.24 Million

Others Institutions Holding EXAS

# of Institutions

610

Shares Held

166M

Call Options Held

1.93M

Put Options Held

1.23M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.8B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pegasus Partners Ltd. with notifications on news.

Account

Pegasus Partners Ltd. Exact Sciences Corp Transaction History